NEXT day delivery available - 3pm cut off
Worldwide shipping available
Free standard UK delivery on orders over £100
This article is intended for qualified aesthetic practitioners. It is not treatment advice for members of the public.
Revolax filler is a South Korean range of monophasic, BDDE-crosslinked hyaluronic acid gels supplied in three strengths: Fine, Deep and Sub-Q. All three share the same HA concentration and lidocaine content, so the real choice comes down to gel firmness, injection depth and the area you are treating. This article sets out what the manufacturer's specifications actually say, how each product maps to common indications, and where practitioners tend to go wrong when they treat the range as interchangeable.
According to the brand's own material properties page, every product in the line contains 24 mg/ml hyaluronic acid and 0.3% lidocaine, in a 1.1 ml syringe. The HA is produced by bacterial fermentation (Streptococcus zooepidemicus), is 100% crosslinked with BDDE, and the brand states that BDDE residue in the finished product is "not detected" following dialysis. Storage is listed as 2–25°C with a 24-month shelf life, which makes the range easy to keep at room temperature in most clinics without a dedicated fridge.
The range is marketed in the UK as a CE-marked Class III medical device. Because the three products share a concentration, the differences between them come from crosslinking and gel structure rather than how much HA is in the syringe. That matters when you are explaining product choice to colleagues or trainees: "same mg/ml" does not mean "same behaviour in tissue".
The manufacturer's specification table gives the following for each product. Durations are the brand's stated ranges, not guarantees, and real-world longevity varies with area, volume, metabolism and technique.
Revolax Fine is the softest gel in the line. Its natural home is fine, static lines in thin skin where a firmer product would risk palpability or a visible ridge: perioral lines, fine crepey lines on the neck, and etched lines that remain after other treatments. Inject in small aliquots with a linear threading or micro-droplet technique, and avoid overcorrection; soft gels in superficial planes are the most likely to show a Tyndall effect if placed too shallow or in excess.
Some practitioners also use Fine for subtle lip hydration or first-time lip patients who want minimal change. It gives less projection than Deep, which can be an advantage for a conservative result, but it will not hold a defined border or vermilion shape in the same way.
Revolax Deep is the workhorse of the range. The brand lists lips, deep nasolabial folds and general contouring as indications. In the lips it offers more body than Fine, which helps with border definition, Cupid's bow support and body augmentation. In the nasolabial fold it can be placed in the deep dermis or the subcutaneous plane, often with a cannula from a single entry point to reduce passes.
Because it is a firmer gel, Deep is less forgiving if it is placed too superficially in thin perioral skin. Early swelling and firmness in the lips are common with firmer gels in the first days, so set expectations at consultation, use conservative volumes at a first session, and review at two weeks before adding product.
Revolax Sub-Q is the most robust gel, designed for structural work: chin projection, malar support, jawline definition and non-surgical rhinoplasty. These are areas where you want lift and shape retention rather than spread. It is supplied with a 25G needle and is placed in the deep subcutaneous plane, either as small depots by needle or by fanning with a cannula.
Nose work deserves a specific mention. The nasal dorsum and tip sit over an end-arterial blood supply with a well-documented risk of vascular occlusion and, rarely, visual complications. Sub-Q's firmness makes it suitable for the indication on paper, but this is advanced work that should only be done by practitioners with specific nasal training, a clear understanding of the vascular anatomy, and an emergency protocol and supplies on site.
A useful rule of thumb with any three-tier range is to match gel firmness to tissue depth and the amount of lift you need. Superficial and mobile areas suit softer gels; deep, static, structural areas suit firmer ones. Applied to Revolax:
Layering is common in full-face work. A firmer product for the deep structural layer with a softer product above to refine contour is a well-established approach across most filler brands, and the Revolax range lends itself to it because all three share the same HA base.
Each box ships with needles in the gauge matched to the gel (30G, 27G and 25G respectively). Many practitioners prefer a blunt-tip cannula for nasolabial folds, marionette lines and cheek work to reduce the number of entry points and the risk of intravascular injection, while keeping needles for precise depot placement or for lip borders. Our earlier piece on choosing a cannula for dermal filler covers gauge and length selection in more detail.
Whatever the tool, the fundamentals do not change: aspirate where appropriate (accepting its limitations), inject slowly with low pressure, keep volumes modest per pass, watch the skin for blanching or livedo, and stop immediately if the patient reports disproportionate pain.
Practitioners often ask how Revolax sits against established brands such as Juvéderm, Restylane and Teosyal. A fair comparison looks at the published evidence base, the breadth of the range and the cost per syringe, not just the mg/ml figure.
The larger European and American brands offer more products tuned to specific indications (for example dedicated tear trough, lip-only or skin-quality gels) and generally have a larger body of peer-reviewed clinical data. Revolax keeps things simpler with three general-purpose strengths, which many clinics like for stock control and training. For a deeper look at the alternatives, see our articles on the Juvéderm range and lip filler brands compared.
Whichever brand you use, the outcome depends far more on assessment, anatomy and technique than on the label. Choose a product whose rheology suits the indication, and stay with it long enough to learn how it behaves in your hands.
Dermal fillers are regulated as medical devices in the UK. MHRA guidance on regulating medical devices in the UK states that CE-marked devices are accepted on the Great Britain market until, at the latest, 30 June 2030, depending on device type and classification, and that all devices must be registered with the MHRA before being placed on the GB market.
In practice, that means buying Revolax, like any filler, from a supplier who can provide genuine stock with intact packaging, visible CE marking, batch and lot numbers, and patient record stickers. Record the lot number in the patient's notes for every syringe. If a complication or a product-quality concern arises, report it through the MHRA Yellow Card scheme. Store boxes within the stated 2–25°C range, away from direct heat and sunlight, and rotate stock so that the shortest-dated syringes are used first.
The brand lists contraindications including pregnancy and breastfeeding, known hypersensitivity to hyaluronic acid, a tendency to hypertrophic scarring, active skin inflammation or infection in the treatment area, and treatment immediately before or after laser, chemical peel or dermabrasion. The lidocaine component means you should also screen for lidocaine allergy. Keep an up-to-date vascular occlusion protocol and emergency kit available in any clinic offering HA filler.
Revolax is a CE-marked, BDDE-crosslinked HA filler with a simple three-product range, and it is widely used in UK clinics. It has a smaller published evidence base than the largest global brands, so it suits practitioners who value a straightforward range and are comfortable assessing results in their own patient population. As with any filler, technique and patient selection drive outcomes.
The manufacturer lists lips under Revolax Deep, and most practitioners use Deep for volume and border definition. Revolax Fine is an option for subtle hydration or a very natural first treatment. Start conservatively with either and review at two weeks.
Neither is better in every situation. Juvéderm offers a wider portfolio of indication-specific gels and more published clinical data; Revolax offers three general-purpose strengths with the same HA concentration. The right choice depends on the indication, your training and experience with each product, and your patients' expectations.
The brand states 9–12 months for Fine and 12–18 months for Deep and Sub-Q. Longevity varies with treatment area, volume, injection depth and the individual patient, so present these as typical ranges rather than promises.
Revolax is marketed as a CE-marked Class III medical device. MHRA guidance accepts CE-marked devices on the GB market until 30 June 2030 at the latest, depending on type and classification, and devices must be registered with the MHRA. Always check packaging for the CE mark and lot numbers, and buy only from suppliers who can show the provenance of their stock.
Revolax filler gives clinics a compact range that covers most HA indications: Fine for superficial lines, Deep for lips and folds, and Sub-Q for structural contouring. The shared 24 mg/ml concentration simplifies stock, but the three gels behave very differently in tissue, so match product to plane and indication rather than reaching for one syringe for everything. You can view the full Revolax range on Filler World, available to qualified practitioners.
